A detailed history of Engineers Gate Manager LP transactions in Royalty Pharma PLC stock. As of the latest transaction made, Engineers Gate Manager LP holds 70,857 shares of RPRX stock, worth $1.87 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
70,857
Previous 142,453 50.26%
Holding current value
$1.87 Million
Previous $4 Million 46.24%
% of portfolio
0.06%
Previous 0.12%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$27.46 - $31.33 $1.97 Million - $2.24 Million
-71,596 Reduced 50.26%
70,857 $2.15 Million
Q4 2023

Feb 14, 2024

BUY
$26.21 - $29.22 $1.37 Million - $1.53 Million
52,290 Added 57.99%
142,453 $4 Million
Q3 2023

Nov 14, 2023

BUY
$26.26 - $31.38 $310,997 - $371,633
11,843 Added 15.12%
90,163 $2.45 Million
Q2 2023

Aug 14, 2023

BUY
$29.6 - $36.56 $2.32 Million - $2.86 Million
78,320 New
78,320 $2.41 Million
Q4 2022

Feb 14, 2023

BUY
$39.17 - $44.04 $2.93 Million - $3.3 Million
74,880 New
74,880 $2.96 Million
Q2 2022

Aug 15, 2022

SELL
$37.53 - $44.22 $5.19 Million - $6.11 Million
-138,281 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$37.46 - $42.44 $2.77 Million - $3.14 Million
73,870 Added 114.69%
138,281 $5.39 Million
Q4 2021

Feb 14, 2022

BUY
$35.17 - $42.48 $726,682 - $877,721
20,662 Added 47.23%
64,411 $2.57 Million
Q3 2021

Nov 15, 2021

SELL
$36.14 - $42.24 $2.56 Million - $3 Million
-70,920 Reduced 61.85%
43,749 $1.58 Million
Q2 2021

Aug 16, 2021

BUY
$39.85 - $46.63 $1.86 Million - $2.18 Million
46,739 Added 68.8%
114,669 $4.7 Million
Q1 2021

May 17, 2021

BUY
$42.34 - $52.82 $2.88 Million - $3.59 Million
67,930 New
67,930 $2.96 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.5B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.